Where I would invest $5,000 in the share market

If I had $5,000 to invest I would consider putting it in the shares of CSL Limited (ASX:CSL) and…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While $5,000 might not sound like it could be a life-changing amount of money to invest, if you can afford to invest this sum of money on an annual basis for an extended period it certainly could be.

According to Fidelity, the local share market has provided an average annual return of 9.8% over the last three decades.

This means that if you had invested $5,000 each year over the last 30 years it would have grown to be worth just short of $875,000 today. Two years later, if the returns stayed the same, this figure would have made you a millionaire with a small fortune of approximately $1,065,000.

While there is no guarantee that the market will provide the same level of return over the next three decades, I'm optimistic that it will.

With that in mind, here are two shares which I think could provide market-beating returns over the long term:

CSL Limited (ASX: CSL)

CSL is a global biotech company which I believe is one of the best buy and hold investment options on the Australian market. This high-quality company has been a consistently strong performer over the long term and shows no signs of breaking the trend in the near future. During August the company reported its full year results and posted a 15% increase in revenue to US$7.6 billion and a 29% jump in net profit after tax to US$1.73 billion. Management appears confident that its positive performance will continue in FY 2019 and has provided guidance of net profit after tax in the range of US$1,880 million to US$1,950 million.

Xero Limited (ASX: XRO)

Xero is an accounting software company growing at an impressively strong rate thanks to the increasing popularity of its high-quality product. At the last count there were 1.4 million users of its software, putting the company on an annualised monthly recurring revenue (AMRR) of $484.4 million. These subscriber numbers could be given a major lift if it can successfully penetrate the massive U.S. market. While progress has been slower than many had expected, I believe in time it will carve out a meaningful slice of the lucrative market. I think Xero is a standout pick in the industry and a far better option than rivals MYOB Group Ltd (ASX: MYO) and Reckon Limited (ASX: RKN).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen
Growth Shares

2 great ASX shares to buy for 2026: experts

These ASX shares are expected to deliver big returns in 2026…

Read more »

woman looking at iPhone whilst working on a laptop
Growth Shares

3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

Read more »

Two large bulls fight against each other in the dust.
Growth Shares

2 quality ASX 200 stocks to buy for your 2026 portfolio

Brokers are bullish on these mainstay sector picks.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »